Onshoring can’t happen in two years. Eli Lilly’s new facility is five years out, and US production can raise generic prices 20-50%. Real security comes from diversification: multiple qualified suppliers in multiple countries, not blunt protectionism that taxes allies and rivals alike.

Tariffs on generic drugs won’t secure America’s medicine supply. They’ll raise prices, push low-margin generics off the market, and leave patients with fewer options. Tariffs are paid by American importers, not foreign companies, and patients can’t just skip insulin or chemo. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Calling it a “negotiation” doesn’t change what it is. Under the IRA, regulators set the price and manufacturers either accept it or face massive penalties. A government-set price backed by coercive penalties is still a price control. Patients may wait longer for the next cure. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Cigarettes remain widely available while vaping faces flavor bans and one of the @FDA's most restrictive approval processes. Yet it's the burning of tobacco, not the nicotine, that causes most of the harm from cigarettes. Regulation should match actual risk. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

States Should Not Wait Until 2028 to Open PBMs’ Books Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

"Most favored nation" drug pricing sounds simple: peg US prices to what Europe pays. But that means American drug prices get set by foreign price caps and bureaucrats, not by a functioning market. That's not a fix, that's outsourcing the problem. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Congress created 340B for vulnerable patients, not vulnerable balance sheets. Time to require real reporting, cut off hospitals that don't need it, and move toward point of sale discounts so the discount actually follows the patient, not the institution.

The 340B drug discount program was built to help low-income patients afford medicine. But GAO found nearly half of hospitals reviewed couldn't show they passed savings to uninsured patients at all. That's not a safety net, that's a loophole. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

For many rural patients, treating the flu or strep throat can mean hours of travel, missed work, and higher costs. Pharmacists are among the most accessible healthcare professionals and can safely test and treat many routine conditions under clear statewide protocols. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Healthcare workers are in short supply, especially in rural communities. Interstate licensure compacts make it easier for qualified clinicians to practice across state lines and through telemedicine, expanding access without spending another taxpayer dollar. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Public health policy should distinguish between combustible cigarettes and lower-risk, noncombustible alternatives. Yet the @FDA continues approving new cigarette products while imposing new restrictions on flavored vapes that make them less convenient for adults trying to quit smoking. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

A business shouldn't need permission from its largest competitor to open. Yet in many states, birth centers need hospital approval, transfer agreements, or physician signoff just to operate. Safety requires clear standards—not giving incumbent hospitals veto power over lower-cost competitors. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Patients shouldn't have to wait weeks for treatment of routine illnesses. Empowering pharmacists to test and treat common conditions like the flu and strep throat can reduce wait times, lower costs, and free doctors to focus on complex care. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Mobile healthcare is proving its value. More than 3,600 mobile clinics now provide millions of patient visits each year—an 80% increase since 2013. But outdated regulations, from Certificate of Need requirements to arbitrary mileage caps, continue to limit access for the patients who need care most. It's time to modernize the rules. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

States don't eliminate sports betting by banning it. They decide whether it happens in a regulated market or through offshore websites, illegal bookies, and gray-market platforms. The real policy choice isn't gambling or no gambling—it's legal markets versus illegal markets. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

Richmond Times-Dispatch: The FDA Finally Allowed Flavored Vapes—With Biometric Surveillance Attached theamericanconsumer.org/2026…

Hospital prices can vary by tens of thousands of dollars for the exact same procedure—even within the same city. Yet patients often don’t know the cost until the bill arrives. Transparency rules exist, but weak penalties and limited enforcement mean many hospitals still treat compliance as optional. Patients deserve real price transparency before they receive care. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…

The FDA Is Regulating Against Reality on Flavored Vapes theamericanconsumer.org/2026…

Most Favored Nation drug pricing isn't a market-based reform—it's a price control tied to the lowest prices set by foreign governments. Lower prices may sound appealing, but reducing expected returns can mean less investment in developing the next generation of medicines. Read more by @JustinLeventhal here: theamericanconsumer.org/2026…